Announcement on Resignation of Senior Management Member
Filed with SSE · · 2 pages · Chinese
Shenzhen Chipscreen Biosciences Co. Ltd. on 6ix
Earlier from Shenzhen Chipscreen Biosciences
- 2025 Semi-annual Report
- Announcement on Acceptance of Application for Issuance of A Shares to Specific Objects in 2024 by SSE
- Announcement on Continuing to Use Temporarily Idle Raised Funds for Cash Management
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development
Later from Shenzhen Chipscreen Biosciences
- Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
- Special Report on the Use of Previously Raised Funds
- Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for A-shares Issuance to Specific Objects in 2024
- Indicative Announcement on Equity Change of Shareholder with Over 5% Shares Reaching an Integral Multiple of 5% Scale
- Announcement on Convening the Q3 2025 Performance Briefing
Follow Shenzhen Chipscreen Biosciences into a list and get an email when it puts out news.
Follow Shenzhen Chipscreen Biosciences